NANO MRNA Co.,Ltd.
4571.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.56 | 0.77 | -0.05 | 0.43 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | -35.97 | -44.44 | -32.02 | -77.67 |
| Quality | ||||
| ROIC | -7.79% | -5.75% | -8.09% | -3.13% |
| Gross Margin | 74.62% | 81.69% | 91.20% | 64.47% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -10.88% | -21.58% | -18.73% | -17.82% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 4.04 | 5.28 | 4.15 | 16.05 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 57.67 | 3.49 | 5.53 | 45.92 |
| Cash Conversion Cycle | 9.41 | 25.79 | 16.28 | 36.34 |